13F filing recap · Q2 2024

What did Torray Investment Partners buy in Q2 2024?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Torray account, including accounts that belong to no fund below.

Stock value

$669.43M

Positions

Estimated turnover

8.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

ULTAUlta Beauty, Inc.$8.51Mreported value+22.0K shares CASYCasey’s General Stores, Inc.$3.98Mreported value+10.4K shares CCCCcc Intelligent Solutions Holdings Inc.$1.23Mreported value+110.6K shares NVDANvidia Corp$370.6Kreported value+3.0K shares RYCEYRolls-Royce Holdings Plc$286.0Kreported value+50.0K shares

Increased positions

BRK.BBerkshire Hathaway Inc$26.19Mreported value+279 shares+0.4%RPRXRoyalty Pharma Plc$18.29Mreported value+23.5K shares+3.5%HDHome Depot, Inc.$16.72Mreported value+1.1K shares+2.4%PSXPhillips 66$16.63Mreported value+2.7K shares

Reduced positions

GOOGLAlphabet Inc.$32.49Mreported value-223 shares-0.1%FISVFiserv Inc$22.56Mreported value-110 shares-0.1%EOGEog Resources, Inc.$18.38Mreported value-568 shares-0.4%JPMJPMorgan Chase & Co$17.11Mreported value-8.0K shares

Exited positions

KHCKraft Heinz Co$3.32Mprior reported value-90.0K shares-100.0%GMABGenmab A/s$3.23Mprior reported value-107.9K shares-100.0%IDXXIdexx Laboratories Inc /de$207.3Kprior reported value-384 shares-100.0%ABTAbbott Laboratories$204.6Kprior reported value-1.8K shares